T Fleming

580 total citations
9 papers, 461 citations indexed

About

T Fleming is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, T Fleming has authored 9 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 3 papers in Surgery and 3 papers in Oncology. Recurrent topics in T Fleming's work include Cancer Diagnosis and Treatment (3 papers), Oral health in cancer treatment (2 papers) and Esophageal Cancer Research and Treatment (2 papers). T Fleming is often cited by papers focused on Cancer Diagnosis and Treatment (3 papers), Oral health in cancer treatment (2 papers) and Esophageal Cancer Research and Treatment (2 papers). T Fleming collaborates with scholars based in United States, United Kingdom and Canada. T Fleming's co-authors include Ralph Vance, S E Rivkin, W. J. Stuckey, Zwi Steiger, H. Gunter Seydel, Lawrence Leichman, Elizabeth Poplin, JP Nicholl, Alan Rees and Jonathan Roberts and has published in prestigious journals such as Journal of Clinical Oncology, Health Technology Assessment and Investigational New Drugs.

In The Last Decade

T Fleming

9 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T Fleming United States	5	291	267	73	47	44	9	461
Christine Pollicino Australia	9	252 0.9×	51 0.2×	141 1.9×	42 0.9×	30 0.7×	12	421
Mark Kuebeler United States	7	199 0.7×	393 1.5×	29 0.4×	14 0.3×	33 0.8×	10	527
Susan L. Rohland Canada	10	114 0.4×	109 0.4×	84 1.2×	113 2.4×	30 0.7×	16	367
Emily J. Guerard United States	13	110 0.4×	73 0.3×	270 3.7×	17 0.4×	131 3.0×	28	761
C W Vickery United Kingdom	5	500 1.7×	500 1.9×	177 2.4×	23 0.5×	10 0.2×	7	697
Doranne L. Hilarius Netherlands	9	94 0.3×	181 0.7×	233 3.2×	17 0.4×	32 0.7×	20	504
Kjersti Hornslien Norway	9	206 0.7×	66 0.2×	364 5.0×	20 0.4×	4 0.1×	13	464
Milica Milakovic Canada	12	63 0.2×	170 0.6×	93 1.3×	5 0.1×	18 0.4×	19	507
Jocelyne Meuric France	8	60 0.2×	114 0.4×	166 2.3×	85 1.8×	6 0.1×	12	624
Laura López Spain	10	35 0.1×	112 0.4×	40 0.5×	26 0.6×	14 0.3×	40	290

Countries citing papers authored by T Fleming

Since Specialization

Citations

This map shows the geographic impact of T Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Fleming more than expected).

Fields of papers citing papers by T Fleming

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Fleming. The network helps show where T Fleming may publish in the future.

Co-authorship network of co-authors of T Fleming

This figure shows the co-authorship network connecting the top 25 collaborators of T Fleming. A scholar is included among the top collaborators of T Fleming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Fleming. T Fleming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Czoski‐Murray, Carolyn, M Lloyd Jones, Colm McCabe, et al.. (2012). What is the value of routinely testing full blood count, electrolytes and urea, and pulmonary function tests before elective surgery in patients with no apparent clinical indication and in subgroups of patients with common comorbidities: a systematic review of the clinical and cost-effective literature. Health Technology Assessment. 16(50). i–xvi, 1. 123 indexed citations

2.

Bellm, Lisa A., June Eilers, Joel B. Epstein, et al.. (2002). Defining Clinically Meaningful Outcomes in the Evaluation of New Treatments for Oral Mucositis: Oral Mucositis Patient Provider Advisory Board. Cancer Investigation. 20(5-6). 793–800. 53 indexed citations

3.

Toth, Béla B., Mark S. Chambers, & T Fleming. (1996). Prevention and management of oral complications associated with cancer therapies: radiotherapy/chemotherapy.. PubMed. 113(6). 23–9. 4 indexed citations

4.

Poplin, Elizabeth, T Fleming, John S. Macdonald, et al.. (1993). Amonafide treatment of refractory esophageal cancer. Investigational New Drugs. 11(1). 47–51. 3 indexed citations

5.

Kraut, Eric H., T Fleming, Michal Segal, et al.. (1991). Phase II study of pibenzimol in pancreatic cancer. Investigational New Drugs. 9(1). 95–96. 32 indexed citations

6.

Poplin, Elizabeth, T Fleming, Lawrence Leichman, et al.. (1987). Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG-8037).. Journal of Clinical Oncology. 5(4). 622–628. 240 indexed citations

7.

Poplin, Elizabeth, et al.. (1986). Southwest oncology group 8037 combined therapy for squamous cell carcinoma of the esophagus. 5. 80. 1 indexed citations

8.

Fleming, T, et al.. (1970). The treatment of uric acid urolithiasis with particular reference to the southwestern U.S.A.. PubMed. 27(1). 68–9. 2 indexed citations

9.

Fleming, T. (1966). Carcinomatous neuromyopathies. A review of neurological syndromes associated with malignant neoplasms and unrelated to metastases.. PubMed. 62(3). 225–31. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact